The contradictory results between research and clinical phenomena indicate the complexity of AGTR1 in regulating the pathological process of PD, which further attracts us to explore whether AGTR1 downregulation has neuroprotective effects in the CNS. The gene discussed is AGTR1; the disease is Parkinson disease.